1-236686571-GCGCCCGC-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001103.4(ACTN2):c.-84_-78del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00317 in 1,312,918 control chromosomes in the GnomAD database, including 63 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.011 ( 25 hom., cov: 30)
Exomes 𝑓: 0.0021 ( 38 hom. )
Consequence
ACTN2
NM_001103.4 5_prime_UTR
NM_001103.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.94
Genes affected
ACTN2 (HGNC:164): (actinin alpha 2) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a muscle-specific, alpha actinin isoform that is expressed in both skeletal and cardiac muscles. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 1-236686571-GCGCCCGC-G is Benign according to our data. Variant chr1-236686571-GCGCCCGC-G is described in ClinVar as [Likely_benign]. Clinvar id is 296493.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0111 (1679/150916) while in subpopulation AFR AF= 0.0361 (1486/41214). AF 95% confidence interval is 0.0345. There are 25 homozygotes in gnomad4. There are 804 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1679 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTN2 | NM_001103.4 | c.-84_-78del | 5_prime_UTR_variant | 1/21 | ENST00000366578.6 | NP_001094.1 | ||
ACTN2 | NM_001278343.2 | c.-84_-78del | 5_prime_UTR_variant | 1/21 | NP_001265272.1 | |||
ACTN2 | NR_184402.1 | n.92_98del | non_coding_transcript_exon_variant | 1/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTN2 | ENST00000366578.6 | c.-84_-78del | 5_prime_UTR_variant | 1/21 | 1 | NM_001103.4 | ENSP00000355537 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1671AN: 150818Hom.: 25 Cov.: 30
GnomAD3 genomes
AF:
AC:
1671
AN:
150818
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00214 AC: 2483AN: 1162002Hom.: 38 AF XY: 0.00205 AC XY: 1162AN XY: 567226
GnomAD4 exome
AF:
AC:
2483
AN:
1162002
Hom.:
AF XY:
AC XY:
1162
AN XY:
567226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0111 AC: 1679AN: 150916Hom.: 25 Cov.: 30 AF XY: 0.0109 AC XY: 804AN XY: 73762
GnomAD4 genome
AF:
AC:
1679
AN:
150916
Hom.:
Cov.:
30
AF XY:
AC XY:
804
AN XY:
73762
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Dilated Cardiomyopathy, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Hypertrophic cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at